David S Tierney is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 348,874 shares of CPRX, which is worth approximately $8.11 Million. The most recent transaction as insider was on Aug 21, 2024, when has been sold 15,000 shares (Common Stock, par value $0.001 per share) at a price of $20.1 per share, resulting in proceeds of $301,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 349K
0% 3M change
4.6% 12M change
Total Value Held $8.11 Million

David S Tierney Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2024
SELL
Open market or private sale
$301,500 $20.1 p/Share
15,000 Reduced 4.12%
348,874 Common Stock, par valu...
Aug 21 2024
BUY
Exercise of conversion of derivative security
$60,150 $4.01 p/Share
15,000 Added 3.96%
363,874 Common Stock, par valu...
Apr 08 2024
SELL
Open market or private sale
$392,000 $15.68 p/Share
25,000 Reduced 6.69%
348,874 Common Stock, par valu...
Apr 08 2024
BUY
Exercise of conversion of derivative security
$100,250 $4.01 p/Share
25,000 Added 6.27%
373,874 Common Stock, par valu...
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
4,000 Added 1.13%
348,874 Common Stock, par valu...
Jan 02 2024
BUY
Exercise of conversion of derivative security
$11,299 $1.13 p/Share
10,000 Added 2.82%
344,874 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.4%
334,874 Common Stock, par valu...
Dec 12 2023
SELL
Open market or private sale
$666,000 $13.32 p/Share
50,000 Reduced 13.04%
333,541 Common Stock, par valu...
Dec 12 2023
BUY
Exercise of conversion of derivative security
$56,499 $1.13 p/Share
50,000 Added 11.53%
383,541 Common Stock, par valu...
May 11 2023
BUY
Exercise of conversion of derivative security
$15,800 $0.79 p/Share
20,000 Added 5.66%
333,541 Common Stock, par valu...
Apr 05 2023
SELL
Open market or private sale
$504,899 $16.83 p/Share
30,000 Reduced 8.73%
313,541 Common Stock, par valu...
Apr 05 2023
BUY
Exercise of conversion of derivative security
$23,700 $0.79 p/Share
30,000 Added 8.03%
343,541 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
4,000 Added 1.26%
313,541 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
1,334 Added 0.43%
309,541 Common Stock, par valu...
Aug 22 2022
SELL
Open market or private sale
$283,200 $14.16 p/Share
20,000 Reduced 6.09%
308,207 Common Stock, par valu...
Aug 22 2022
BUY
Exercise of conversion of derivative security
$50,600 $2.53 p/Share
20,000 Added 5.74%
328,207 Common Stock, par valu...
May 20 2022
SELL
Open market or private sale
-
20,000 Reduced 6.09%
308,207 Common Stock, par valu...
May 20 2022
BUY
Exercise of conversion of derivative security
$50,600 $2.53 p/Share
20,000 Added 5.74%
328,207 Common Stock, par valu...
Dec 03 2021
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.43%
308,207 Common Stock, par valu...
Aug 13 2021
SELL
Open market or private sale
$304,000 $6.08 p/Share
50,000 Reduced 14.01%
306,874 Common Stock, par valu...
Aug 13 2021
BUY
Exercise of conversion of derivative security
$156,000 $3.12 p/Share
50,000 Added 12.29%
356,874 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
1,333 Added 0.43%
306,874 Common Stock, par valu...

Also insider at

KMPH
KEMPHARM, INC Healthcare
DST

David S Tierney

Director
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX